Frontiers in Oncology | Breast Cancer

Original Research

Accepted on 09 Jul 2025

Multidimensional Evaluation of 3.0T HR-MRI, Ultrasound Imaging, and GATA3 Protein Expression in Breast Cancer, and Their Prognostic Analysis

in Breast Cancer

Yang Bai
Ting Xie
Xiangyang Mo
Yong Luo
Man Chen

Frontiers in Oncology

doi 10.3389/fonc.2025.1587243

Opinion

Accepted on 09 Jul 2025

Redefining "Normal": Discovery of Aneuploid Epithelial Cells in Healthy Breast Tissue

in Breast Cancer

Xiaoyan Chen
Zhi Li

Frontiers in Oncology

doi 10.3389/fonc.2025.1558977

Original Research

Accepted on 09 Jul 2025

Exploration of the clinical prognostic model of BRCA based on PCAT7

in Breast Cancer

Zhi Zhang
Chaocheng Xiang
Tong Chen
Aimin Ma
Xu Wang
Jiaying Li
Yixuan Chen
Chengyu Huang
Ting Li
Danmei Wu

Frontiers in Oncology

doi 10.3389/fonc.2025.1580858

Original Research

Published on 09 Jul 2025

Study on the diagnostic value of folic acid-targeted nano-microbubbles in breast microcarcinoma

in Breast Cancer

Nianyu Xue
Zhenyu Shen
Zhenbin Xu
Shengmin Zhang

Frontiers in Oncology

doi 10.3389/fonc.2025.1512422

270 views

Original Research

Published on 09 Jul 2025

A real-world study of palbociclib plus endocrine therapy with or without a short course chemotherapy in the first-line treatment of HR-positive HER2-negative metastatic breast cancer

in Breast Cancer

Xiangjun Li
Yuhua Song
Meng Lv
Yongmei Wang
Xueqiang Gao
Tianyi Ma
Teng Ma
Changgen Liu
Xinyi Sun
Haibo Wang

Frontiers in Oncology

doi 10.3389/fonc.2025.1512496

321 views

Review

Published on 09 Jul 2025

The impact of estrogen on benign breast tumors and exploration of recurrence mechanisms

in Breast Cancer

Zhe Fan
Huijin Wang
Yu Liu
Zongshuo Yu
Jingjing Li
Yuan Teng

Frontiers in Oncology

doi 10.3389/fonc.2025.1609832

260 views

Original Research

Published on 09 Jul 2025

Clinical characteristics, treatment, and survival of thrombocytopenia induced by T-DM1 in early HER2-positive breast cancer

in Breast Cancer

Fang Wang
Xiaosan Zhang
Xiuchun Chen
Lu Zhang
Zhenzhen Liu

Frontiers in Oncology

doi 10.3389/fonc.2025.1592440

208 views

Original Research

Accepted on 08 Jul 2025

SHCBP1 drives tumor progression in triple-negative breast cancer

in Breast Cancer

Huiling Wang
Huijuan Dai
Liheng Zhou
Yanping Lin
Wenjin Yin
Jingsong Lu

Frontiers in Oncology

doi 10.3389/fonc.2025.1587236

Original Research

Published on 08 Jul 2025

Association between neutrophil-lymphocyte ratio and female breast cancer: an observational study from NHANES 2001-2018 with external validation

in Breast Cancer

Juan Xiong
Deju Zhang
Jing Wu
Peili Yang
Donghai Shi
Xiaolan Zhou
Ying Yuan
Chuntao Quan
Ni Xie

Frontiers in Oncology

doi 10.3389/fonc.2025.1564238

302 views

Original Research

Published on 08 Jul 2025

Patients’ daily reporting of symptoms via mobile application reveals a significant difference between patients’ perceptions and doctors’ interpretations

in Breast Cancer

Cvetka Grašič Kuhar
Nina Privšek
Marjetka Sraka
Ema Grašič
Timotej Kovač
Matjaž Kukar

Frontiers in Oncology

doi 10.3389/fonc.2025.1595322

231 views

Correction

Accepted on 07 Jul 2025

Advanced (non-metastatic) triple negative breast cancer - An open label Phase 2 Randomized controlled trial

in Breast Cancer

Vinod Ramani
Ajaikumar Basavalinga Sadashivaiah
Radheshyam Naik

Frontiers in Oncology

doi 10.3389/fonc.2025.1658958

150 views

Original Research

Accepted on 07 Jul 2025

Using Baseline MRI Radiomics to Predict the Tumor Shrinkage Patterns in HR-Positive, HER2-Negative Breast Cancer

in Breast Cancer

Lijia Wang
Yongchen Wang
Li Yang
Jialiang Ren
Qian Xu
Yingmin Zhai
Tao Zhou

Frontiers in Oncology

doi 10.3389/fonc.2025.1539644

131 views

Original Research

Accepted on 03 Jul 2025

Oral microbiome components predict response to neoadjuvant chemotherapy in triple-negative breast cancer patients

in Breast Cancer

Xiaoyan Fu
Ze Huang
Zongyan Li
Zuxiao Chen
Zhijie Wu
Qingyu Yang
Haiyan Li

Frontiers in Oncology

doi 10.3389/fonc.2025.1546044

143 views

Original Research

Published on 02 Jul 2025

Expression of Insulin-like growth factor 2 mRNA-binding protein 3 and its diagnostic value in breast cancer

in Breast Cancer

Chao-Qun Wang
Jun-Kang Shao
Yan Wang
Shi-Ping Lu
Li-Jing Jiang
Zhi-Qun Du
Bi-Fei Huang

Frontiers in Oncology

doi 10.3389/fonc.2025.1624870

329 views

Systematic Review

Published on 01 Jul 2025

Impact of blood lipid levels on breast cancer prognosis: a systematic review and meta-analysis

in Breast Cancer

Jiaqing Song
Ying Jin
Qinghong Yu
Hongting Wu
Xiufei Gao

Frontiers in Oncology

doi 10.3389/fonc.2025.1496468

318 views

Original Research

Accepted on 30 Jun 2025

JMJD8 Overexpression in Breast Cancer: Implications for Diagnosis, Prognosis, and Immune Microenvironment Interactions

in Breast Cancer

Chenlei Zhu
Tianyi Xi
Guorong Yang
Wen Lu
Sentai Wang
Jiwei Cao

Frontiers in Oncology

doi 10.3389/fonc.2025.1536278

161 views